96774 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses; DNA viruses Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
PEPMIXES TO GENERATE MULTIVIRAL CTLS WITH BROAD SPECIFICITY
#2Vaccines For Recurrent Respiratory Papillomatosis And Methods Of Using The Same
#3CPG AMPHIPHILES AND USES THEREOF
#4NANOPARTICLES AS CARRIER-SYSTEM FOR ADJUVANTS/ANTIGENS
#5METHODS FOR TREATING CANCER WITH ACTIVATING ANTIGEN CARRIERS
#6Virus-Like Particle Conjugates
#7CPG AMPHIPHILES AND USES THEREOF
#8CHIMERIC PAPILLOMAVIRUS L1 PROTEIN
#9CHIMERIC PAPILLOMAVIRUS L1 PROTEIN
#10CHIMERIC PAPILLOMAVIRUS L1 PROTEIN
#11CHIMERIC PAPILLOMAVIRUS L1 PROTEIN
#12CHIMERIC PAPILLOMAVIRUS L1 PROTEIN
#13CHIMERIC PAPILLOMAVIRUS L1 PROTEIN
#14CHIMERIC PAPILLOMAVIRUS L1 PROTEIN
#15CHIMERIC PAPILLOMAVIRUS L1 PROTEIN
#16CHIMERIC PAPILLOMAVIRUS L1 PROTEIN
#17CHIMERIC PAPILLOMAVIRUS L1 PROTEIN
#18CHIMERIC PAPILLOMAVIRUS L1 PROTEIN
#19VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS
#20Vaccines For Recurrent Respiratory Papillomatosis And Methods Of Using The Same
#21IMMORTALIZED KERATINOCYTES, LENTIVIRUS FOR KERATINOCYTE IMMORTALIZATION, AND METHODS OF USE
#22Modification of gene transcription and translation efficiency by 5′UTR sequence variation
#23COMPOSITION OF NANOPARTICLES AS CARRIER FOR HPV-DERIVED IMMUNOGENIC FRAGMENTS
#24T CELL RECEPTORS AND ENGINEERED CELLS EXPRESSING SAME
#25COMPOSITIONS COMPRISING ANNEXIN V AND HPV TUMOR ANTIGEN FUSION POLYPEPTIDES AND METHODS FOR MAKING AND USE
#26Immunologically Active Peptide-Biliverdin Conjugate, Preparation Method Therefor and Application Thereof
#27Virus-like particle conjugates
#28HPV VACCINES
#29Virus-like particle conjugates for diagnosis and treatment of tumors
#30METHODS FOR TREATING CANCER WITH ACTIVATING ANTIGEN CARRIERS
#31Chimeric papilloma virus L1 protein
#32Pepmixes to generate multiviral CTLS with broad specificity
#33Ii vaccine adjuvant
#34Virus-like particle conjugates for diagnosis and treatment of tumors
#35VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS
#36Vaccines for recurrent respiratory papillomatosis and methods of using the same
#37Pepmixes to generate multiviral CTLs with broad specificity
#38Mutant of L1 protein of human papillomavirus type 66
#39Mutant of L1 protein of human papillomavirus type 39
#40VACCINES WITH INTERLEUKIN-33 AS AN ADJUVANT
#41CpG amphiphiles and uses thereof
#42HPV vaccines
#43Cutaneous papilloma virus vaccine
#44Virus-like particle conjugates for diagnosis and treatment of tumors
#45Therapeutic HPV16 vaccines
#46Ii vaccine adjuvant
#47Virus-like particle conjugates
#48T cell receptors and engineered cells expressing same
#49Therapeutic HPV18 vaccines
#50COMBINATION PRIME: BOOST THERAPY
#51Therapeutic HPV vaccine combinations
#52Immunomodulating composition for treatment
#53Virus-like particle conjugates for diagnosis and treatment of tumors
#54Mutant of L1 protein of human papillomavirus type 11
#55Vaccines with interleukin-33 as an adjuvant
#56LISTERIA-BASED IMMUNOTHERAPY AND METHODS OF USE THEREOF
#57Therapeutic HPV16 vaccines
#58USE OF VLP FOR THE DETECTION OF NUCLEIC ACIDS
#59MANUFACTURING METHOD OF AN IMMUNOTHERAPEUTIC FORMULATION COMPRISING A RECOMBINANT LISTERIA STRAIN
#60THERAPEUTIC VACCINE FOR TREATING OR PREVENTING MERKEL CELL POLYOMA VIRUS-ASSOCIATED TUMORS
#61HPV vaccines
#62METHODS FOR POTENTIATING AN IMMUNE RESPONSE USING DEPOT-FORMING AND NON-DEPOT-FORMING VACCINES
#63Combination Therapies With Recombinant Listeria Strains
#64Lactic-acid-bacteria-containing composition, oral pharmaceutical composition for treating HPV infection and/or HPV-associated tumors, and mucosal immunity-inducing agent
#65Therapeutic HPV18 vaccines
#66Combination Of Listeria-Based Vaccine With Anti-OX40 Or Anti-GITR Antibodies
#67HPV-related fusion protein and applications thereof
#68Therapeutic HPV16 vaccines
#69Method for enhancing immunogenicity of epitope peptide of HPV antigen, virus-like particle, and method for preparing HPV vaccine
#70Therapeutic HPV18 vaccines
#71Immunogenic JC polyomavirus compositions and methods of use
#72Vaccines with interleukin-33 as an adjuvant
#73Therapeutic HPV16 vaccines
#74Truncated L1 protein of human papillomavirus type 6
#75Truncated L1 protein of human papillomavirus type 52
#76Truncated L1 protein of human papillomavirus type 6